Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>IDH1+ R/R > Treatment > FR. S. Ivosidenib 250 mg Tab. > Patent>Assignee; Claims; No.; Etc.

This data is not available for free


Patent>Assignee; Claims; No.; Etc.'s products
This section has no products